| 2 -0.085 (-4.08%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.6  |
1-year : | 3.15 |
| Resists | First : | 2.23 |
Second : | 2.7 |
| Pivot price | 2  |
|||
| Supports | First : | 1.47 |
Second : | 1.22 |
| MAs | MA(5) : | 2.29 |
MA(20) : | 1.91 |
| MA(100) : | 2.77 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 58.4 |
D(3) : | 77.6 |
| RSI | RSI(14): 46.5 |
|||
| 52-week | High : | 15.64 | Low : | 1.47 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TIVC ] has closed above bottom band by 49.7%. Bollinger Bands are 46.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.1 - 2.11 | 2.11 - 2.12 |
| Low: | 1.94 - 1.95 | 1.95 - 1.97 |
| Close: | 1.98 - 2 | 2 - 2.02 |
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Thu, 11 Dec 2025
Tivic Health acquires manufacturing assets, launches CDMO subsidiary - Investing.com
Thu, 11 Dec 2025
Tivic Health (Nasdaq: TIVC) adds CDMO unit to speed Entolimod manufacturing - Stock Titan
Tue, 18 Nov 2025
Tivic Health (NASDAQ: TIVC) to Present Entolimod ARS Data in BARDA TechWatch Meeting - Stock Titan
Sat, 15 Nov 2025
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2025 Earnings Call Transcript - Insider Monkey
Fri, 14 Nov 2025
Tivic Health Systems Advances Biologics Pipeline - TipRanks
Fri, 14 Nov 2025
Tivic Reports Third Quarter 2025 Financial Results - ACCESS Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1.58e+006 (%) |
| Held by Institutions | 7.6 (%) |
| Shares Short | 37 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -7.4e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 700.6 % |
| Return on Equity (ttm) | -96.2 % |
| Qtrly Rev. Growth | 482000 % |
| Gross Profit (p.s.) | 8.03 |
| Sales Per Share | -89.99 |
| EBITDA (p.s.) | -141414 |
| Qtrly Earnings Growth | -8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 1.17 |
| Dividend | 0 |
| Forward Dividend | 41320 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|